Anti-Aging, Longevity, Life Extension and Biotechnology Information
Anti-Aging, Longevity, Life Extension and Biotechnology Information
Anti-Aging Medicine, Anti-Ageing Medicine, Antiaging Medicine
Tools » Drug Information
Related Drug Reading

Skin & Allergy News - Caduet

April 1, 2004 -- (amlodipine besylate and atorvastatin, Pfizer) A combined formulation of the long-acting calcium channel blocker Norvasc (amlodipine) with the...

Internal Medicine News - Caduet

March 15, 2004 -- (amlodipine besylate and atorvastatin, Pfizer) A combined formulation of the long-acting calcium channel blocker Norvasc (amlodipine) with the...

Internal Medicine News - New indication for Caduet

January 1, 2005 -- The combination drug Caduet (amlodipine besylate/atorvastatin calcium) is indicated for the prevention of cardiovascular disease to lower the risk of...

Chain Drug Review - Caduet cleared by FDA

February 16, 2004 -- The FDA has approved Pfizer Inc.'s Caduet, developed for the treatment of hypertension and cholesterol, major risk factors for cardiovascular...

Nurse Practitioner - Caduet Treats Two Cardiovascular Conditions at Once

June 1, 2004 -- In January 2004, the Food and Drug Administration (FDA) approved the new combination drug, Caduet for the treatment of high blood pressure and high...

PR Newswire Europe - JEWEL Programme Results Show That a New Therapy, Caduet(R), can Optimise Treatment for Patients With Hypertension and Additional Cardiovascular (CV) Risk...

June 13, 2006 -- MADRID, Spain, June 13 /PRNewswire/ -- - Caduet, Single-Pill Amlodipine and Atorvastatin Combination, Helps Patients Reduce Calculated Risk for...

Internal Medicine News - Caduet boosts success rates: single-pill combo therapy for hypertension, dyslipidemia

May 1, 2004 -- NEW ORLEANS -- The recently approved single-pill amlodipine/atorvastatin combination markedly improves the likelihood that patients with concomitant...

Business Wire - Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide

June 18, 2008 -- Ranbaxy to Receive License in U.S. on November 30, 2011; Pfizer to Host Conference Call Today at 9 a.m. EDT NEW YORK -- Pfizer Inc announced...

Business Wire - A Professional Thought Leader Analysis of Non-Interventional Cardiology and Major Industry Drugs

July 7, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/ce5f70/thought_leader_ins) has announced the addition of the...

Market Wire - Examine the Lipitor Market Analysis and Forecasts Report, 2007-2012, 2017 and 2023

June 25, 2008 -- Reportlinker.com announces that a new market research report related to the Cardiovascular diseases industry is available in its catalogue. Lipitor...


Drugs By Name
Drugs By Manufacturer
Partners
The following health oriented websites are recommended:
> Drug Topics
> Health Topics
> HGH Doctor
> HGH News
> Medaus Compounding Center
> Performance Enhancing Drugs
> Personal Trainer Search
> Testosterone News

Destinations
The following on-site destinations recommended:
> Anti-Aging
> Anti-Aging Books
> Anti-Aging Feeds
Site Tree | Disclaimer
Link Index | Resources | More Resources
What is Anti-Aging, Anti-Ageing or Antiaging?
Compounding Pharmacy | HGH News | Personal Trainer Search | AAR Dir | Health Topics | OOF CMS v3.5
© Copyright 2003- Odin Metatech, Inc, All Rights Reserved. Copyright violations will be prosecuted to the fullest extent of the law. Why plagerize? Use our free RSS feeds for syndication.
We are not affiliated with the American Academy for Anti-Aging Medicine (A4M)

Powered by Odin Assemble v2.0